| Literature DB >> 33089087 |
Sevil Okan1, Ayla Çağlıyan Türk2.
Abstract
OBJECTIVES: In this study, we aimed to compare the efficiency of ultrasound, mucopolysaccharide polysulfate phonophoresis, ketoprofen phonophoresis and exercise combinations in terms of pain, functionality, disability, and strength in patients with lateral epicondylitis (LE). PATIENTS AND METHODS: This prospective, parallel-group, randomized-controlled clinical study included a total of 60 patients (42 males, 18 females; mean age 38.08 years; range, 21 to 50 years) with LE between April 2016 and October 2017. The patients were equally randomized into four groups based on the time of admission to the outpatient clinic. The Visual Analog Scale (VAS), painless weight lifting, the Patient- Rated Tennis Elbow Evaluation (PRTEE), and Quick Disabilities of Arm, Shoulder and Hand (QuickDASH) were used to measure the outcomes. The measurements were performed at baseline, at the end of 10 daily sessions, and after a six-week follow-up period.Entities:
Keywords: Ketoprofen; lateral epicondylitis; mucopolysaccharide polysulfate
Year: 2020 PMID: 33089087 PMCID: PMC7557626 DOI: 10.5606/tftrd.2020.4433
Source DB: PubMed Journal: Turk J Phys Med Rehabil ISSN: 2587-1250
Baseline demographic and clinical characteristic of patients
| Groups | |||||||||||||
| MPS (n=15) | Ketoprofen (n=15) | Ultrasound (n=15) | Control (n=15) | ||||||||||
| Variables | n | % | Mean±SD | n | % | Mean±SD | n | % | Mean±SD | n | % | Mean±SD | |
| Age (year) | 38.8±7.5 | 39.1±10.5 | 38.3±7.7 | 36.1±7.2 | 0.758 | ||||||||
| Disease duration (month) | 2.2±1.2 | 1.9±1.1 | 2.1±0.9 | 1.8±1.0 | 0.737 | ||||||||
| Sex | 0.999 | ||||||||||||
| Female | 10 | 66.7 | 11 | 73.3 | 11 | 73.3 | 10 | 66.7 | |||||
| Male | 5 | 33.3 | 4 | 26.7 | 4 | 26.7 | 5 | 33.3 | |||||
| Dominant side | 0.999 | ||||||||||||
| Right | 14 | 93.3 | 15 | 100 | 14 | 93.3 | 15 | 100 | |||||
| Left | 1 | 6.7 | 0 | 0 | 1 | 6.7 | 0 | 0 | |||||
| Affected side | 0.928 | ||||||||||||
| Right | 11 | 73.3 | 9 | 60 | 10 | 66.7 | 11 | 73.3 | |||||
| Left | 4 | 26.7 | 6 | 40 | 5 | 33.3 | 4 | 26.7 | |||||
| MPS: Mucopolysaccharide polysulfate; SD: Standard deviation; Independent samples t-test or chi-square test were used. | |||||||||||||
Cronbach alpha values for questionnaires
| Questionnaires | First measurement | Second measurement | Third measurement |
| PRTEE pain with 5 items | 0.821 | 0.850 | 0.911 |
| PRTEE function with 10 items | 0.929 | 0.926 | 0.969 |
| Quick DASH with 11 items | 0.850 | 0.857 | 0.911 |
| Quick DASH work model with 4 items | 0.972 | 0.967 | 0.990 |
| PRTEE: Patient-Rated Tennis Elbow Evaluation; DASH: Disabilities of the arm, shoulder and hand. | |||
Distribution of repeated quantitative measures according to patient groups
| Groups | |||||
| Variables | MPS | Ketoprofen | Ultrasound | Control | |
| Resting VAS baseline | 4.9±3.0a | 4.7±3.2a | 3.1±2.3a | 4.5±3.0a | 0.352 |
| Resting VAS 10th day | 2.5±2.8b | 2.3±2.3b | 1.1±1.6b | 2.8±2.5b | 0.243 |
| Resting VAS 6 weeks | 1.5±2.6b | 0.4±0.8c | 1.3±2.6ab | 1.1±1.7b | 0.505 |
| <0.001 | <0.001 | <0.001 | <0.001 | ||
| p‡=0.272; Power for interaction=0.447 | |||||
| Pressure VAS baseline | 7.6±2.2a | 8.1±1.4a | 7.5±1.9a | 7.6±1.5a | 0.798 |
| Pressure VAS 10th day | 4.8±1.7b | 4.9±2.5b | 4.4±2.8b | 4.7±1.9b | 0.946 |
| Pressure VAS 6 weeks | 2.9±3.0c | 2.9±2.7c | 2.5±3.0c | 2.5±1.9c | 0.963 |
| <0.001 | <0.001 | <0.001 | <0.001 | ||
| p‡=0.997; Power for interaction=0.065 | |||||
| Activity VAS baseline | 7.9±1.8a | 8.2±1.7a | 7.3±2.3a | 8.3±1.4a | 0.453 |
| Activity VAS 10th day | 5.7±2.4b | 5.3±2.0b | 4.5±2.4b | 5.1±1.6b | 0.524 |
| Activity VAS 6 weeks | 2.7±2.9c | 2.8±2.7c | 3.1±3.3c | 2.1±2.0c | 0.759 |
| <0.001 | <0.001 | <0.001 | <0.001 | ||
| p‡=0.341; Power for interaction=0.393 | |||||
| Lifted weight baseline | 2.0±1.3a | 1.6±0.9a | 1.8±1.3a | 2.1±1.3a | 0.727 |
| Lifted weight 10th day | 2.8±1.3b | 2.6±1.4b | 3.5±1.6b | 2.9±1.4b | 0.370 |
| Lifted weight 6 weeks | 4.1±1.3c | 3.7±1.5c | 4.1±1.8b | 3.9±1.5b | 0.849 |
| <0.001 | <0.001 | <0.001 | <0.001 | ||
| p‡=0.577; Power for interaction=0.271 | |||||
| PRTEE baseline | 57.2±17.3a | 64.8±20.0a | 55.4±11.1a | 57.9±16.2a | 0.427 |
| PRTEE 10th day | 35.6±16.7b | 34.8±15.5b | 33.8±15.0ab | 33.2±17.7b | 0.980 |
| PRTEE 6 weeks | 23.9±23.1c | 18.4±16.6c | 26.3±23.4b | 21.3±22.4c | 0.774 |
| <0.001 | <0.001 | <0.001 | <0.001 | ||
| p‡=0.354; Power for interaction=0.353 | |||||
| QuickDASH baseline | 46.5±17.2a | 51.1±16.1a | 47.1±13.1a | 39.2±16.9a | 0.331 |
| QuickDASH 10th day | 26.4±17.0b | 28.3±11.5b | 23.7±14.4ab | 21.6±15.8b | 0.628 |
| QuickDASH 6 weeks | 12.1±12.2c | 9.3±10.2c | 17.0±20.6b | 10.9±13.9c | 0.550 |
| <0.001 | <0.001 | <0.001 | <0.001 | ||
| p‡=0.325; Power for interaction=0.377 | |||||
| QuickDASH work model baseline | 52.6±23.0a | 51.4±23.1a | 51.3±22.5a | 25.0±17.7a | 0.116 |
| QuickDASH work model 10th day | 33.3±26.4b | 27.1±18.2b | 33.0±17.6b | 8.3±10.2a | 0.154 |
| QuickDASH work model 6 weeks | 18.3±23.5c | 9.0±12.2c | 23.2±26.8b | 0±0b | 0.151 |
| <0.001 | <0.001 | <0.001 | <0.001 | ||
| p‡=0.683; Power for interaction=0.205 | |||||
| p* Between-subjects comparison (One-way ANOVA); p† Within-subject Comparisons (Repeated measures ANOVA); p‡: Interaction (Two-way repeated measures ANOVA); abc: In a same column for repeated measurements in each group, common subscripts indicate statistical indifference (e.g.:a-a) and different subscripts indicate statistical difference (e.g.:a-b)p p† Power was found = 1 (100%) for all repeated measures ANOVA test results. | |||||